Other OTC - Delayed Quote USD

Viveve Medical, Inc. (VIVE)

0.0002 -0.0001 (-33.33%)
At close: April 26 at 2:20 PM EDT
Key Events
Loading Chart for VIVE
DELL
  • Previous Close 0.0003
  • Open 0.0002
  • Bid --
  • Ask --
  • Day's Range 0.0002 - 0.0002
  • 52 Week Range 0.0001 - 0.1107
  • Volume 11,527
  • Avg. Volume 2,949
  • Market Cap (intraday) 2,145
  • Beta (5Y Monthly) 0.14
  • PE Ratio (TTM) --
  • EPS (TTM) -2.6500
  • Earnings Date Apr 29, 2024 - May 2, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.

www.viveve.com

47

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: VIVE

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

VIVE
0.00%
S&P 500
6.92%

1-Year Return

VIVE
99.57%
S&P 500
25.26%

3-Year Return

VIVE
99.99%
S&P 500
22.00%

5-Year Return

VIVE
100.00%
S&P 500
74.29%

Compare To: VIVE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: VIVE

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    2.14k

  • Enterprise Value

    -23.86k

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.00

  • Price/Book (mrq)

    0.00

  • Enterprise Value/Revenue

    -0.00

  • Enterprise Value/EBITDA

    0.00

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -62.13%

  • Return on Equity (ttm)

    -210.99%

  • Revenue (ttm)

    6.83M

  • Net Income Avi to Common (ttm)

    -28.14M

  • Diluted EPS (ttm)

    -2.6500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.91M

  • Total Debt/Equity (mrq)

    507.94%

  • Levered Free Cash Flow (ttm)

    -7.58M

Research Analysis: VIVE

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: VIVE

Fair Value

0.0002 Current
 

Dividend Score

0 Low
VIVE
Sector Avg.
100 High
 

Hiring Score

0 Low
VIVE
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
VIVE
Sector Avg.
100 High
 

People Also Watch